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Abstract In this study, we investigated the synergistic effects
of Staphylococcus aureus extracts (membranes and walls) and
lipopolysaccharide (LPS) derived from Escherichia coli on
tumor necrosis factor (TNF) production in the pathogenesis of
silica-induced inflammation. The synergistic induction of
TNF by silica particles (<20 µm) in combination with either
S. aureus extracts or LPS was examined in J774A.1 cell
cultures. Media from the treated and untreated cell cultures
were assayed for TNF, using the mouse WEHI 164 cell
cytotoxicity assay and enzyme immunoassay. Cells exposed
simultaneously to silica and 0.5 µg/ml S. aureus extracts (or
0.5 ng/ml of LPS) produced a significantly higher level of TNF
than those produced by the inducer alone. Our results indicate
that device-associated infections (or pyrogen contamination)
could enhance inflammatory responses, because of particles
produced by the wear of medical implants or particulate
biomaterials used for clinical purposes.
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Silica (SiO
2
) is a material that may produce particle-related
inflammatory responses, such as chronic inflammation,
granuloma formation, and lung fibrosis. Hazardous exposure
to silica may occur in mining, quarrying, glass manufacture,
the production of pottery, porcelain and lining bricks, or
during boiler descaling and enameling. Other significant
exposures may occur from wear particles emanating from
medical devices such as dental resin composites, bone
cement, and silica xerogel. [2, 13, 14, 17, 21, 28, 32].
Several investigators have measured cytokine production
in mononuclear cells exposed to various sources of silica.
Claudio et al. [6] showed a significant production of tumor
necrosis factor (TNF) in RAW 264.7 cells exposed to silica
particles in vitro, and Perkins et al. [25] measured cellular
release of interleukin (IL)-1β, TNF-α, IL-6, granulocyte
macrophage colony stimulating factor, and prostaglandin
E
2
 during in vitro culture, as indicators of asbestos-induced
macrophage activation.
The effects of silica exposure on the macrophage secretion
of proinflammatory cytokines and on macrophage responses
to lipopolysaccharide (LPS) have not been fully characterized.
It has been suggested that silica particles, due to synergistic
effects between the particles and LPS, stimulate macrophage
response to LPS treatment, resulting in the increased secretion
of TNF-α.
Studies of clinical retrievals indicate that a few species seem
to dominate biomaterial-centered infections. Staphylococcus
aureus and S. epidermidis have most frequently been isolated
from infected biomaterial surfaces, but Escherichia coli,
Pseudomonas aeruginosa, Proteus mirabilis, β-hemolytic
streptococci, and enterococci have also been isolated.
Therefore, we investigated the ability of Gram-positive S.
aureus and LPS derived from E. coli to induce TNF-α in
macrophage cells in vitro.
Silica particles (Sigma; MO, U.S.A.) used in this study
had a maximal diameter <20 µm, which can be phagocytosed
by macrophages. Macrophage cells (J774A.1) and S.
aureus were obtained from the American Type Culture
Collection (Rockville, MD, U.S.A.). J774A.1 cells were
grown at 37
o
C in a humidified atmosphere (5% CO
2
/95%
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air) in a macrophage culture medium, which consisted of
RPMI1640 with L-glutamine, 10% fetal bovine serum (FBS),
100 U/ml penicillin, and 100 µg/ml streptomycin. LPS
(strain: E. coli) was purchased from Sigma Chem., Co.
(St. Louis, MO, U.S.A.). LPS products were lyophilized
powders prepared by phenol extraction and contained
10,000 endotoxin units per mg LPS. Bacterial cultures
(Nutrient broth) of S. aureus were grown from a single
colony picked from freshly streaked plates using a similar
method as previously described [24]. Staphylococcus aureus
was incubated for 12-16 h at 37
o
C with vigorous shaking,
and the bacterial cells were harvested by centrifugation
at 6,000 ×g for 10 min. Immediately after harvesting, the
bacteria were suspended in 0.1 M sodium citrate (pH 3.0)
to give a concentration of 4 g of wet cells/10 ml. The
suspension of cell pellets was ultrasonicated at 20 kC using
a sonicator (XL-2020; Misonix; NY, U.S.A.) for 15 min at
4
o
C, and then dialyzed against distilled water (DW) for
24 h at 4
o
C. The suspension of broken cells was decanted,
and the pH was adjusted to 4.7 with 1 M NaHCO
3
. An
equal volume of 80% (w/v) aqueous phenol was added,
and the mixture was stirred for 1 h at 65
o
C. After cooling,
the emulsion was centrifuged at 1,500 ×g for 10 min, the
aqueous layer was removed, and the phenol layer was
washed with 1 volume of DW. Both the aqueous and phenol
layers were dialyzed against DW, and both fractions were
then lyophilized.
Before incubation with macrophages, silica particles were
washed with 70% ethanol and evaluated for the possibility
of LPS-contamination, using the Limulus Amebocyte Lysate
(LAL) test with a sensitivity of 10 pg/ml. The silica particles
were then coated with FBS, essentially by published procedure
[12].
TNF-α levels in cultured media were measured by using
the WEHI 164 cell-cytotoxicity assay [11]. When cell
cultures were 90% confluent, they were washed with PBS
and digested with trypsin-EDTA (0.25% porcine trypsin,
0.02% EDTA in Hank’s balanced salt solution) for 10 min
and plated at an initial density of 2×10
5
cells/well in 96-
well plates. After a 12 h incubation period, the medium
was removed and confluent cell monolayers were further
incubated for 24 h with 200 µl of the conditioned media
from silica and/or S. aureus extracts (or LPS) treated
macrophage cells. After 24 h of incubation, the medium
was removed, and adherent viable WEHI 164 cells were
stained with 0.2% crystal violet in 2% ethanol for 10 min
at room temperature. After extensive lysis of the stained
cells with 0.5% SDS in 50% ethanol, absorbance was
measured at 595 nm using an automated plate reader.
Percent cytotoxicity was calculated from the following
equation: (1-OD of test/OD of control)×100. Cytotoxic
titers (U/ml) were expressed as reciprocal values of the
dilution that showed 50% cytotoxicity of target cells, as
described previously [1]. The units of TNF were calculated
based on the cytotoxicity of known concentrations of murine
recombinant (mr)TNF-α (Serotec, U.K.) in the standard
curve of the same assay.
TNF-α was also measured in an enzyme-linked
immunoadsorbent assay (Endogen, MA, U.S.A.) according
to package insert directions. This assay is specific for the
measurement of natural and recombinant murine TNF-α,
and detects a minimum level of 10 pg/ml of biologically
active TNF-α.
In order to confirm the TNF-α activity of conditioned
media, the neutralization effect of anti-TNF-α antibody on
conditioned media was investigated. As shown in Fig. 1,
anti-mouse TNF-α antibodies (IgG concentration, 10 µg/
ml) caused a significant inhibition (approximately 90%) of
the cytotoxicity of WEHI 164 cells mediated by silica, S.
aureus extracts, or LPS-treated culture media. This is
consistent with the previous reports [7, 23, 34] that TNF-α
or TNF-like molecules mediate the cytolysis of WEHI 164
cells during monocyte/macrophage-supernatant treatment.
These results indicate that most of the cytotoxic activity
would be due to TNF-α.
Supernatants of silica-treated macrophage cultivation
demonstrated a dose-dependent increase of specific lysis
against WEHI 164 cells in the range from 0.5 to 8 mg
(silica)/well (Fig. 2A). The intensity of cytotoxic responses
demonstrated by the conditioned media from S. aureus
extracts (0.4 to 50 µg/ml) and LPS (0.4 to 50 ng/ml)-
treated J774A.1 cells showed a similar pattern in terms of
TNF titers against WEHI 164 cells (Fig. 2B, 2C). Although
Claudio et al. [6] reported that J774A.1 cells showed a
small increase of TNF-α production when treated with
Fig. 1. Inhibition of the cytolytic activity of silica, S. aureus
(membranes and walls), and LPS-treated macrophage culture
media on WEHI 164 sarcoma cells by anti-TNF-α antibodies.
Silica particles were added at a concentration of 4 mg/well. Membranes
and walls of S. aureus were prepared from ultrasonicated S. aureus cell
suspensions, as described in the text. Staphylococcus aureus (membranes
and walls) extracts and LPS were used at concentrations of 10 µg/ml and
10 ng/ml, respectively. Each point represents average± SEM of four
determinations. *Statistically different from the nontreated control group,
p<0.05.
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LPS, J774A.1 cells showed 35-fold increase of TNF-α
secretion in response to LPS in the present assay system
(Fig. 2C).
When J774A.1 macrophages were exposed to 0.5-4 mg/
well silica particles for 24 h, a dose-dependent increase of
specific lysis against WEHI 164 cells was observed over
the levels observed in the nontreated control macrophages
(Fig. 2C). The macrophage-derived cytokine TNF-α has
been implicated in the inflammatory response to a host of
biomaterials, and TNF-α is considered to be the initiator
protein of particle disease, leading to aseptic loosening of
endoprostheses [9, 15, 31]. Boynton et al. [4] observed a
significant elevation of TNF-α secretion by human monocyte-
derived macrophage in response to high-density polyethylene
particles, and Rader et al. [26] demonstrated in vitro
induction of TNF-α by cobalt, polyethylene, alumina ceramic
(Al
2
O
3
), and zirconium dioxide in a human monocytic cell
line. Several investigators have suggested that biological
molecules adsorbed onto particles may play a key role in
determining macrophage response [3, 27, 33]. Adsorbed
endotoxins may be of particular importance, since they are
either exogenously or endogenously present widely, and
strongly adhere to many biomaterials. It is widely accepted
that the main proinflammatory mediators induced by bacteria
and their cell wall components are cytokines, primarily
TNF-α, IL-1, and IL-6 [16, 22]. The main bacterial
components responsible for the induction of these clinical
manifestations are endotoxin (LPS) in Gram-negative bacteria
[5, 20], and peptidoglycan (PepG) and lipoteichoic acid
(LTA) in Gram-positive bacteria [8, 10]. The main target
cells activated by these bacterial components are monocytes
and macrophages, which are activated through two pattern
recognition receptors, CD14 and Toll-like receptors (TLRs)
[8, 10]. In the present study, we observed synergistic TNF-
α induction in J774A.1 cells exposed to combinations of
low concentrations of either S. aureus extracts or LPS and
silica particles. Compared with the nonstimulated control
group, cells cultured with 0.5 mg/well of silica, 0.5 µg/ml
of S. aureus extracts, or 0.5 ng/ml of LPS produced an
identical and minimum TNF-α release (Fig. 3). When 0.5 mg/
well of silica was added together with either 0.5 µg/ml of
S. aureus extracts or 0.5 ng/ml of LPS, TNF-α production
was significantly higher after treatment than that observed
after the addition of inducer alone (Fig. 3, P<0.05).
Studies of clinical retrievals indicate that a few species seem
to dominate biomaterial-centered infections. Staphylococcus
aureus and S. epidermidis have been most frequently
Fig. 2. Production of supernatant TNF-α by silica (A), S. aureus
extracts (membranes and walls, B), and LPS-treated J774A.1 (C).
J774A.1 cells (4×10
5
cells/well) were cultured as described in the text
for 24 h in 24-well plates, and silica, S. aureus extracts, and LPS were
added at the indicated concentrations. After 24 h of incubation, the
supernatants were collected to determine the specific lysis of WEHI 164
sarcoma cells. The units of TNF-α were calculated based on the
cytotoxicity of known concentrations of murine recombinant (mr)TNF-α
in the standard curve of the same assay. Each point represents
average±SEM of four determinations.
Fig. 3. Synergistic TNF-α induction in J774A.1 cells exposed
to a combination of low concentration of S. aureus extracts (or
LPS) and silica particles.
Cells were cultured and treated with 0.5 mg of silica particles and 0.5 µg/
ml of S. aureus extracts (or 0.5 ng/ml of LPS) for 24 h. The amounts of
TNF-α in the treated and control samples were measured in an enzyme-
linked immunoadsorbent assay according to package insert directions.
Each point represents average±SEM of four determinations. *Statistically
different from silica, S. aureus extracts, LPS, and nontreated cells, p<0.05.
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isolated from infected biomaterial surfaces. Therefore, this
work has shown that implant-associated infection and
corrosion of implanted medical devices may produce acute
and chronic inflammatory responses in the host. In
addition to the Gram-positive bacterial infection (such as
S. aureus and S. epidermidis) at the implantation site,
pyrogenic contamination (Gram-positive organisms related)
of implanted biomaterials may cause inflammatory stimulation.
LAL test (pyrogenicity testing) has been performed extensively
in the medical device and pharmaceutical industries.
However, the limitation of the test is that it detects only the
pyrogens of Gram-negative bacterial endotoxin. Consequently,
even though the biomedical materials were contaminated
with Gram-positive bacteria, the specimen could be judged
to comply with the bacterial endotoxin limit for medical
devices.
How Gram-positive organisms initiate an inflammatory
response is not yet clear. It is difficult to pinpoint one
component (such as LPS for Gram-negative organisms) that
is responsible for initiating Gram-positive inflammation.
Previous studies [8, 30] have shown that the cellular
components of Gram-positive organisms, such as LTA and
PepG, can produce an inflammatory response. In our study,
the membranes of S. aureus were extracted with a phenol-
water mixture, in order to exclude the possible involvement
of teichoic acid in the membrane of S. aureus for the
stimulation of TNF-α. The activity of TNF-α induction was
mainly found in the phenol layer, but also in the aqueous
layer to a lesser extent, where lipoglycan of membranes
was generally thought to be accumulated (Table 1). This is
in agreement with the currently held opinion that the two
bacterial wall components, PepG and LTA, work together
to cause systemic inflammation associated with Gram-
positive organisms.
Our present findings showed synergistic induction of the
inflammatory cytokine TNF-α by combinations of LPS
with silica particles in the murine macrophage cell line
J774A.1. We previously reported that, when silica particles
(0.5 mg/well) were added together with 5 ng/ml of LPS,
cyclooxygenase-II activity, a useful marker of inflammatory
responses, was increased several-fold, compared with that
caused by the inducer alone [18, 19]. These results suggest
that the intake of silica particles together with a minute
amount of LPS could enhance a significant release of
inflammatory mediators by macrophages in the presence of
implantation-associated infections (or pyrogen contamination).
In addition to the bacterial infection at the implantation
site, pyrogenicity of implanted biomaterials may also cause
trouble. The bacterial endotoxin limit set by the Food and
Drug Administration (FDA) for medical devices is 0.5 EU
(the LAL reactivity of 0.1 ng of US Pharmacopeia Reference
Standard Endotoxin/ml, based on a 40 ml rinse [29]).
Significantly, the concentration of LPS used in our assay
system showed a synergistic induction of TNF, which is
lower than the bacterial endotoxin limit set by the FDA for
medical devices. However, the susceptibilities of cells to
LPS and the biological activities of LPS extracted from
different Gram-negative bacteria vary. It remains to be
determined as to what extent the concentration of LPS
preparations can produce synergistic effects in inducing a
significant release of inflammatory mediators by macrophages.
Further in vitro studies will be necessary to confirm the
diverse sensitivity of LPS on different macrophage cell
lines and different kinds of bacteria.
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